mRNA vaccines could vanquish COVID-19 today, cancer tomorrow
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
As BioNTech and other pharmaceutical companies leapt into action in search of the winning formula, Germany's army of manufacturing and logistics experts would soon prove crucial.
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
U.K. approves Pfizer-BioNTech vaccine for rollout from 'next week'
After months of "rigorous" trials and thorough analysis of the data, the U.K. regulator "concluded that the vaccine has met its strict standards of safety, quality and effectiveness."
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
